Viaskin Peanut

peanut epicutaneous immunotherapy patch · DBV Technologies

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Viaskin Peanut, covering 2012-03-23 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age [Phase 3]